Chondroitin sulfate - Elvetium/Roche
Alternative Names: Chondroitin sulphate - Elvetium/RocheLatest Information Update: 24 Oct 2021
At a glance
- Originator Roche
- Developer Elvetium; Roche
- Class Anti-inflammatories; Antirheumatics; Glycosaminoglycans
- Mechanism of Action Collagen stimulants; Leucocyte elastase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Osteoarthritis
Most Recent Events
- 31 Aug 1999 Launched for Osteoarthritis in Argentina (PO)
- 31 Aug 1999 Registered for Osteoarthritis in Uruguay (PO)